Food and Drug Administration perspective: Advancing product development for non‐healing chronic wounds

Author:

Verma Kapil Dev1ORCID,Lewis Felisa1,Mejia Maryjoy1,Chalasani Meghana2,Marcus Kendall A.1

Affiliation:

1. Division of Dermatology and Dentistry, Office of New Drugs Center for Drug Evaluation and Research, US Food and Drug Administration Silver Spring Maryland USA

2. Office of New Drugs Center for Drug Evaluation and Research, US Food and Drug Administration Silver Spring Maryland USA

Publisher

Wiley

Subject

Dermatology,Surgery

Reference31 articles.

1. An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds

2. Human skin wounds: A major and snowballing threat to public health and the economy

3. SnyderDL SullivanN MargolisDJ SchoellesK.Skin substitutes for treating chronic wounds. Technology Assessment Program Project ID No. WNDT0818. (Prepared by the ECRI Institute‐Penn Medicine Evidence‐based Practice Center under Contract No. HHSA 290–2015‐00005‐I) Rockville MD: Agency for Healthcare Research and Quality.2020.http://www.ahrq.gov/research/findings/ta/index.html.

4. Food and Drug Administration (FDA) drug approval end points for chronic cutaneous ulcer studies

5. Healing Chronic Wounds: Current Challenges and Potential Solutions

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3